US Patent 7230085 Anti-DOTA antibody
Patent 7230085 was granted and assigned to IMMUNOMEDICS, INC. on June, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+244 characters)
Article
Patent abstract
The present invention relates to an antibody or antibody fragment that binds to 1,4,7,10-tetrazacyclododecane-N,N′,N″,N′″-tetraacetic acid (DOTA),which is bound to an alkyl-amino group through one of its pendant carb.oxyl groups.
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07230085 Anti-DOTA antibody US Patent 7230085 Anti-DOTA antibody
Infobox
Patent Number
0723008500
Patent Number
723008500
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072300850
Date of Patent
June 12, 2007
0Patent Application Number
103052680
Date Filed
November 27, 2002
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072300850
Date of Patent
June 12, 2007
0Patent Application Number
103052680
Date Filed
November 27, 2002
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 21 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07230085 Anti-DOTA antibody
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07230085
Date of patent
June 12, 2007
Patent application number
10305268
Date Filed
November 27, 2002
Patent primary examiner
Find more entities like US Patent 7230085 Anti-DOTA antibody
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
